US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Spdr S&P Biotech Etf

154.18

+0.15000.10%

Post-market: 154.500.3200+0.21%19:53 EDT

Volume:8.85M

Turnover:1.37B

Market Cap:10.51B

PE:8.46

High:156.04

Open:154.37

Low:152.50

Close:154.03

52wk High:169.89

52wk Low:93.26

Shares:68.18M

Float Shares:68.18M

Volume Ratio:1.08

T/O Rate:12.99%

Dividend:0.57

Dividend Rate:0.37%

EPS(TTM):18.23

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Health Care Down, but not by Much, on Defensive Bias - Health Care Roundup

Health Care Roundup: Market Talk

Purple Biotech Shareholders Approve All AGM Proposals, File Results with U.S. SEC

Oruka Therapeutics to Attend the 2026 Morgan Stanley Global Healthcare Conference

COMPASS Pathways: Strong Phase 3 TRD Data, Differentiated Positioning Support Unchanged $24 Price Target and Buy Rating

Sector Update: Healthcare

MT Newswires Live

Worldwide Healthcare Trust Tightens Capital Base With Share Buyback

Health Care Roundup: Market Talk

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Pyxis Oncology (PYXS) and Opus Genetics (IRD)

Analysts Have Conflicting Sentiments on These Healthcare Companies: Bristol-Myers Squibb (BMY), Stryker (SYK) and InnovAge Holding (INNV)

Wall Street Analysts Are Bullish on Top Healthcare Picks

Analysts Are Bullish on These Healthcare Stocks: IDEAYA Biosciences (IDYA), Medicus Pharma Ltd (MDCX)

Boan Biotech Confirms Finance Lease Terms After Asset Revaluation

Sector Update: Healthcare Stocks Mixed Premarket Wednesday

MT Newswires Live

Metropolis Healthcare Allots 66,312 Shares Under 2020 RSU Plan

Health Care Select Sector SPDR: Pivot points

Beijing Launches Joint Insurance Body for Biopharma Sector to Strengthen Safeguards for Innovative Medicine Industry

Kane Biotech Schedules Webcast to Detail Wound-Care Commercial Strategy

Avicanna Expands MyMedi.ca Platform with Integrated Medical Cannabis Program in Canadian Healthcare

Incannex Healthcare Provides Corporate Update on Clinical Progress, Intellectual Property and Capital Position

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"Tiger Brokers,U.S. stock trading,Hong Kong stock trading,trading U.S. stocks,stock information,stock prices,U.S. stock quotes,U.S. stock trading,Hong Kong stock trading,IPO trading,buying U.S. stocks,global investment","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/stock/XBI/news?page=9"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"XBI","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"XBI\",,,,,undefined,":{"symbol":"XBI","market":"US","secType":"STK","nameCN":"Spdr S&P Biotech Etf","latestPrice":154.18,"timestamp":1789588800000,"preClose":154.03,"halted":0,"volume":8853285,"hourTrading":{"tag":"盘后","latestPrice":154.5,"preClose":154.18,"latestTime":"19:53 EDT","volume":37711,"amount":5808520.5381,"timestamp":1789602836010,"change":0.32,"changeRate":0.002075,"amplitude":0.004216},"delay":0,"changeRate":0.0009738362656625701,"floatShares":68175000,"shares":68175000,"eps":18.23,"marketStatus":"Not Yet Opened","change":0.15,"latestTime":"09-16 16:00:00 EDT","open":154.37,"high":156.04,"low":152.5,"amount":1368574083.6516001,"amplitude":0.022983,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":18.23,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1789632000000},"marketStatusCode":0,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":154.03,"sharesOutstanding":63325000,"nav":154.028797,"aum":10385391642.43,"dividendRate":0.003696,"bidAskSpread":0.000229,"preHourTrading":{"tag":"盘前","latestPrice":155.02,"preClose":154.03,"latestTime":"09:29 EDT","volume":7820,"amount":1209968.8936,"timestamp":1789565346872,"change":0.99,"changeRate":0.006427,"amplitude":0.006817},"postHourTrading":{"tag":"盘后","latestPrice":154.5,"preClose":154.18,"latestTime":"19:53 EDT","volume":37711,"amount":5808520.5381,"timestamp":1789602836010,"change":0.32,"changeRate":0.002075,"amplitude":0.004216},"volumeRatio":1.077339,"optionData":{"bulkOrders":[{"symbol":"XBI","call":true,"expireDate":1797570000000,"strike":"170.0","timestamp":1789576413951,"price":4.35,"volume":2000,"amount":870000,"type":"*"}]},"impliedVol":0.3321,"impliedVolPercentile":0.7809},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"XBI\",,,,,undefined,":{"symbol":"XBI","floatShares":68175000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.077339,"shares":68175000,"dividePrice":0.5699,"high":156.04,"amplitude":0.022983,"preClose":154.03,"low":152.5,"week52Low":93.26,"pbRate":"--","week52High":169.89,"institutionHeld":0.8511,"latestPrice":154.18,"eps":18.23,"divideRate":0.003696,"volume":8853285,"delay":0,"ttmEps":18.23,"open":154.37,"prevYearClose":121.93,"prevWeekClose":156.2,"prevMonthClose":162.5,"prevQuarterClose":158.25,"fiveDayClose":159.38,"twentyDayClose":160.11,"sixtyDayClose":145.86},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/XBI\",params:#limit:5,,,undefined,":[{"date":"2026-06-22","symbol":"XBI","amount":0.138094,"announcedDate":"2026-06-18","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-22","defaultRemindTime":1782135000000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-24","payableDate":"2026-06-22","currency":"USD","dateTimestamp":1782100800000,"payDate":"2026-06-24"},{"date":"2025-12-22","symbol":"XBI","amount":0.406564,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-24","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-24"},{"date":"2025-09-22","symbol":"XBI","amount":0.02665,"announcedDate":"2025-09-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-22","defaultRemindTime":1758547800000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-24","payableDate":"2025-09-22","currency":"USD","dateTimestamp":1758513600000,"payDate":"2025-09-24"},{"date":"2025-06-23","symbol":"XBI","amount":0.007295,"announcedDate":"2025-06-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-23","defaultRemindTime":1750685400000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-25","payableDate":"2025-06-23","currency":"USD","dateTimestamp":1750651200000,"payDate":"2025-06-25"},{"date":"2025-03-24","symbol":"XBI","amount":0.00525,"announcedDate":"2025-03-21","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-24","defaultRemindTime":1742823000000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-03-26","payableDate":"2025-03-24","currency":"USD","dateTimestamp":1742788800000,"payDate":"2025-03-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"XBI\",market:\"US\",,,undefined,":[{"executeDate":"2016-12-16","recordDate":"2016-12-20","paymentDate":"2016-12-27","value":0.01831,"currency":"USD"},{"executeDate":"2017-03-17","recordDate":"2017-03-21","paymentDate":"2017-03-27","value":0.019702,"currency":"USD"},{"executeDate":"2017-06-16","recordDate":"2017-06-20","paymentDate":"2017-06-26","value":0.110135,"currency":"USD"},{"executeDate":"2017-09-15","recordDate":"2017-09-18","paymentDate":"2017-09-25","value":0.03704,"currency":"USD"},{"executeDate":"2018-03-16","recordDate":"2018-03-19","paymentDate":"2018-03-21","value":0.059081,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"XBI\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"XBI\",pageSize:20,pageCount:9,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2666558859","title":"Health Care Down, but not by Much, on Defensive Bias - Health Care Roundup","url":"https://stock-news.laohu8.com/highlight/detail?id=2666558859","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666558859?lang=en_us&edition=fundamental","pubTime":"2026-09-10 05:07","pubTimestamp":1788988020,"startTime":"0","endTime":"0","summary":"Health-care companies fell, but not by as much as the broad market, as traders rotated into sectors less sensitive to inflation and fuel costs.Tyra Biosciences fell sharply after the performance of a bladder-cancer drug candidate in a mid-stage clinical trial disappointed investors.Johnson & Johnson, which is also developing a bladder-cancer treatment, fell slightly.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LABU","XLV","BK4585","BK4581","JNJ","BK4588","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666304145","title":"Health Care Roundup: Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2666304145","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666304145?lang=en_us&edition=fundamental","pubTime":"2026-09-10 04:50","pubTimestamp":1788987000,"startTime":"0","endTime":"0","summary":"The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET.1107 ET - Recent clinical-trial setbacks mean Novartis needs to ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XBI","LABU","XLV","BK4588","BK4585","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666530139","title":"Purple Biotech Shareholders Approve All AGM Proposals, File Results with U.S. SEC","url":"https://stock-news.laohu8.com/highlight/detail?id=2666530139","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666530139?lang=en_us&edition=fundamental","pubTime":"2026-09-10 04:28","pubTimestamp":1788985724,"startTime":"0","endTime":"0","summary":"An announcement from Purple Biotech ( ($PPBT) ) is now available. Purple Biotech reported that shareholders approved all proposals presented at its...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/purple-biotech-shareholders-approve-all-agm-proposals-file-results-with-u-s-sec?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/purple-biotech-shareholders-approve-all-agm-proposals-file-results-with-u-s-sec?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XBI","BK4585","BK4588","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666766537","title":"Oruka Therapeutics to Attend the 2026 Morgan Stanley Global Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2666766537","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666766537?lang=en_us&edition=fundamental","pubTime":"2026-09-10 04:01","pubTimestamp":1788984060,"startTime":"0","endTime":"0","summary":"MENLO PARK, Calif., Sept.  09, 2026  -- Oruka Therapeutics, Inc.  , a clinical-stage biotechnology company developing novel biologics designed to set a new standard for the treatment of chronic skin diseases including plaque psoriasis and hidradenitis suppurativa, today announced its attendance at the 2026 Morgan Stanley Global Healthcare Conference, taking place in New York, NY from September 14-16, 2026.About Oruka TherapeuticsOruka Therapeutics is developing novel biologics designed to set a new standard for the treatment of chronic skin diseases. Oruka’s mission is to offer patients suffering from inflammatory diseases like plaque psoriasis and hidradenitis suppurativa the greatest possible freedom from their condition by achieving high rates of disease clearance with dosing as infrequently as once or twice a year. For more information, visit www.orukatx.com and follow Oruka on LinkedIn. Investor Contact:Alan Lada-606-7911alan.lada@orukatx.com","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/09/3359049/0/en/oruka-therapeutics-to-attend-the-2026-morgan-stanley-global-healthcare-conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1720051017.SGD","LU2487616109.SGD","LU0158827781.USD","BK4139","LU1162221912.USD","LU0557290698.USD","LU0795875086.SGD","LU0795875169.SGD","LU0106261372.USD","LU1989772840.SGD","LU0128526141.USD","LU0912757837.SGD","LENZ","LU0234570918.USD","LU1064131342.USD","LU2028103732.USD","BK4581","LU0882574139.USD","XLV","LU1791710582.SGD","HCSG","BK4504","BK4516","BK4588","LU2133065610.SGD","LU0390134368.USD","LU0006306889.USD","LU2271345857.HKD","IE00BKVL7J92.USD","IE00B3S45H60.SGD","BK4539","LU2089284900.SGD","BK4534","LU0098860793.USD","LU1732799900.SGD","LABU","KBWB","IAI","BK4137","XBI","LU0528227936.USD","LU1548497426.USD","LU2347655156.SGD","LU0971096721.USD","LU1668664300.SGD","LU1244550577.SGD","BK4007","LU0320765646.SGD","LU2089283258.USD","IE00BZ1G4Q59.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666537973","title":"COMPASS Pathways: Strong Phase 3 TRD Data, Differentiated Positioning Support Unchanged $24 Price Target and Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2666537973","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666537973?lang=en_us&edition=fundamental","pubTime":"2026-09-10 03:55","pubTimestamp":1788983722,"startTime":"0","endTime":"0","summary":"COMPASS Pathways, the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Francois Brisebois from LifeSci Capital reit...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/compass-pathways-strong-phase-3-trd-data-differentiated-positioning-support-unchanged-24-price-target-and-buy-rating-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/compass-pathways-strong-phase-3-trd-data-differentiated-positioning-support-unchanged-24-price-target-and-buy-rating-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","BK4585","BK4581","XBI","XLV","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666453414","title":"Sector Update: Healthcare","url":"https://stock-news.laohu8.com/highlight/detail?id=2666453414","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666453414?lang=en_us&edition=fundamental","pubTime":"2026-09-10 01:04","pubTimestamp":1788973486,"startTime":"0","endTime":"0","summary":"Healthcare stocks declined Wednesday afternoon, with the NYSE Healthcare Index and the State Street Health Care Select Sector SPDR ETF  each shedding 0.4%.The iShares Biotechnology ETF  decreased 0.7%.In corporate news, UnitedHealth  sold an interest in some of its Optum Health operations in Florida to TPG , Bloomberg reported. UnitedHealth shares were down 1.8%.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0011850046.USD","LU2362540622.SGD","BK4533","LU1057294990.SGD","FHLC","LU1037948897.HKD","LU2133065610.SGD","LU0211326839.USD","LU2361045086.USD","UNHW","XLV","LU0266013472.USD","SGXZ81514606.USD","UNH","LU0661504455.SGD","BK4585","IE00B19Z3B42.SGD","LU0149725797.USD","LU0545039389.USD","LU0787776722.HKD","LU0683600562.USD","SG9999014914.USD","LU1119994496.HKD","LU1674673428.USD","LU1934455863.HKD","LU1989771016.USD","SGXZ57979304.SGD","LU0122379950.USD","LU0354030511.USD","LU0496365809.HKD","LU0211328371.USD","BK4581","LU1914381329.SGD","LU1791710582.SGD","IE00B7KXQ091.USD","LU0158827948.USD","LU0708994859.HKD","LU2279689827.SGD","IE00B4JS1V06.HKD","LU0310800379.SGD","IE00B1BXHZ80.USD","IE00B19Z8X17.USD","LU0976567544.SGD","LU0072461881.USD","LU1791710400.SGD","LU0820561909.HKD","LU0310799852.SGD","LU2244417387.USD","IE00BFXG1179.USD","LU0912757837.SGD","SUNH0main","IE00BFSS7M15.SGD","LU0256863811.USD","LU1551013342.USD","LU0058720904.USD","IE0004445239.USD","LU1670627923.USD","IE00B3T34201.USD","LU1267930573.SGD","IE00BJT1NW94.SGD","LU1720051017.SGD","LU2028103732.USD","LU2089984988.USD","LU1037948541.HKD","SG9999014898.SGD","LU0345770993.USD","IE0009355771.USD","JDOC","IE0005OL40V9.USD","LU0107464264.USD","IE00B7SZLL34.SGD","IE00BZ9MQY76.HKD","LU0528227936.USD","LU2089284900.SGD","LU1069347547.HKD","LU1066053197.SGD","LU0109391861.USD","LU1720051108.HKD","IE00B4R5TH58.HKD","UNHU","LU1084165304.USD","LU2417539215.USD","IE00BFSS8Q28.SGD","LU0053666078.USD","LU0187121727.USD","LU0417517546.SGD","LU0114720955.EUR","LU0965508806.USD","LU1291159041.SGD","LU0689472784.USD","LU2112291526.USD","LU2362541513.USD","LU1934455277.USD","SG9999002232.USD","IE00B1XK9C88.USD","LU1674673691.USD","SG9999014880.SGD","LU0316494557.USD","LU0553294199.USD","IE0002141913.USD","LU2125154935.USD","IE00BJJMRY28.SGD","LU0456855351.SGD","IE000M9KFDE8.USD","LU2242649171.HKD","LU0557290698.USD","BK4154","LU0211326755.USD","LU0353189763.USD","LU0965509010.AUD","LU1854104046.USD","LU2461242641.AUD","LABU","LU0738911758.USD","LU0795875086.SGD","LU1670628061.USD","IE0002270589.USD","LU2211815571.USD","IE00B2B36J28.USD","LU1548497426.USD","LU1988902786.USD","HRTS","LU1066051811.HKD","BK4532","LU2468319806.SGD","UN","LU0029864427.USD","BK4534","SG9999017495.SGD","LU1267930227.SGD","LU0143551892.USD","LU0094547139.USD","LU0354030438.USD","LU2347655156.SGD","LU0820562030.AUD","LU0203345920.USD","IE00BJJMRZ35.SGD","LU0052756011.USD","SG9999013999.USD","LU0211327993.USD","IE00B19Z8W00.USD","LU0823416689.USD","LU1003077747.HKD","LU2087625088.SGD","LU2954938101.SGD","SG9999018865.SGD","LU2361044865.SGD","LU0882574055.USD","LU1267930490.SGD","LU1323610961.USD","IE00B19Z9Z06.USD","LU0861579265.USD","IE00BWXC8680.SGD","IE00BSNM7G36.USD","LU0128525689.USD","LU0795875169.SGD","LU1983299246.USD","LU2552382132.HKD","SG9999001176.USD","LU2264538146.SGD","XBI","LU2552382215.SGD","LU0432979614.USD","LU1153585028.USD","LU2456880835.USD","LU2552382058.USD","LU1023059063.AUD","SG9999018857.SGD","LU0128525929.USD","UNHG","LU0158827781.USD","LU0162691827.USD","IE00BJJMRX11.SGD","LU1066051225.USD","LU1732800096.USD","IHF","VHT","LU0965509283.SGD","LU1496350502.SGD","LU0708995401.HKD","IE0004445015.USD","LU2324357040.USD","SGXZ99366536.SGD","LU1267930730.SGD","IE00BKPKM429.USD","LU1934455194.USD","LU2491049909.HKD","IE00B19Z3581.USD","IXJ","LU0310800965.SGD","LU1064131342.USD","LU2271345857.HKD","LU0820561818.USD","IE00BZ1G4Q59.USD","LU0079474960.USD","IE00B775H168.HKD","LU2999663052.SGD","SGXZ51526630.SGD","LU0342679015.USD","LU1074936037.SGD","RXL","LU0048584097.USD","LU2491050071.SGD","LU0353189680.USD","LU2491050154.USD","MHIP","LU0965509101.SGD","LU2111349929.HKD","IYH","SG9999014906.USD","LU1261432733.SGD","BK4588","IE00BFTCPJ56.SGD","LU0672654240.SGD","LU0238689110.USD","IE00B19Z9505.USD","LU2462591277.SGD","LU0203347892.USD","LU0345770308.USD","LU2023251221.USD","LU1061106388.HKD","LU0234572021.USD","IE00BKVL7J92.USD","LU1778281490.HKD","LU1854103824.USD","LU2089283258.USD","LU0289739699.SGD","LU1035773651.USD","LU0320765059.SGD","LU1814569148.SGD","LU2362541273.HKD","SG9999001176.SGD","LU2125154778.USD","LU0097036916.USD","GDOC","TRUH","LU0251132253.USD","LU0077335932.USD","LU2360032135.SGD","LU1718418525.SGD","TMED","LU0949170772.SGD","SG9999002224.SGD","LU1551013425.SGD","LU2361044949.HKD","LU2236285917.USD","LU0198837287.USD","LU0943347566.SGD","BK4566","LU1506573853.SGD","LU1732799900.SGD","SGXZ31699556.SGD","IE00B19Z9P08.USD","LU1066051498.USD","IE00B894F039.SGD","IE00BN29S564.USD","LU2357305700.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666534635","title":"Worldwide Healthcare Trust Tightens Capital Base With Share Buyback","url":"https://stock-news.laohu8.com/highlight/detail?id=2666534635","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666534635?lang=en_us&edition=fundamental","pubTime":"2026-09-10 00:20","pubTimestamp":1788970843,"startTime":"0","endTime":"0","summary":"An announcement from Worldwide Healthcare Trust PLC GBP ( ($GB:WWH) ) is now available. Worldwide Healthcare Trust PLC has undertaken a market purc...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/worldwide-healthcare-trust-tightens-capital-base-with-share-buyback-3?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/worldwide-healthcare-trust-tightens-capital-base-with-share-buyback-3?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XLV","HCSG","BK4137","BK4581","BK4585","XBI","BK4588","LU0128526141.USD","LU0029874061.USD","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666345975","title":"Health Care Roundup: Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2666345975","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666345975?lang=en_us&edition=fundamental","pubTime":"2026-09-10 00:20","pubTimestamp":1788970800,"startTime":"0","endTime":"0","summary":"The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET.1107 ET - Recent clinical-trial setbacks mean Novartis needs to ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4581","BK4585","XBI","LABU","BK4588","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666053135","title":"Analysts’ Opinions Are Mixed on These Healthcare Stocks: Pyxis Oncology (PYXS) and Opus Genetics (IRD)","url":"https://stock-news.laohu8.com/highlight/detail?id=2666053135","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666053135?lang=en_us&edition=fundamental","pubTime":"2026-09-09 23:10","pubTimestamp":1788966623,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Pyxis Oncology (PYXS) and Opus Genetics (IRD). Pyxis Oncology (PY...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-pyxis-oncology-pyxs-and-opus-genetics-ird-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-pyxis-oncology-pyxs-and-opus-genetics-ird-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4581","BK4139","IRD","PY","XLV","BK4585","LU0029874061.USD","PYXS","LABU","XBI","LU0128526141.USD","BK4588","HCSG","BK4007","BK4137"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666539731","title":"Analysts Have Conflicting Sentiments on These Healthcare Companies: Bristol-Myers Squibb (BMY), Stryker (SYK) and InnovAge Holding (INNV)","url":"https://stock-news.laohu8.com/highlight/detail?id=2666539731","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666539731?lang=en_us&edition=fundamental","pubTime":"2026-09-09 22:50","pubTimestamp":1788965412,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Bristol-Myers Squibb (BMY), Stryker (SYK) and Inno...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-bristol-myers-squibb-bmy-stryker-syk-and-innovage-holding-innv-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-bristol-myers-squibb-bmy-stryker-syk-and-innovage-holding-innv-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4559","LU0432979614.USD","IE00BJJMRZ35.SGD","BMY","LU0456855351.SGD","LU1323610961.USD","BK4588","LABU","LU0225284248.USD","LU1670711123.USD","IHI","SYK","XLV","IE0002141913.USD","IHE","LU1983299246.USD","INNV","BK4082","LU1868836757.USD","LU1868837300.USD","LU1718418525.SGD","BK4585","BK4534","HCSG","LU1989771016.USD","LU0029874061.USD","LU1430594728.SGD","GB00B4LPDJ14.GBP","LU1868836914.USD","LU2468319806.SGD","LU0058720904.USD","LU0882574055.USD","IE00BFTCPJ56.SGD","XBI","LU0096364046.USD","LU0267386448.USD","LU2404859741.USD","FTXH","LU1585245621.USD","BK4196","IE0009355771.USD","LU1670710588.SGD","LU2506951875.HKD","BK4007","LU2242652126.USD","BK4137","LU2360032135.SGD","LU0868494617.USD","LU1670710661.SGD","IE00BJT1NW94.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666853924","title":"Wall Street Analysts Are Bullish on Top Healthcare Picks","url":"https://stock-news.laohu8.com/highlight/detail?id=2666853924","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666853924?lang=en_us&edition=fundamental","pubTime":"2026-09-09 22:40","pubTimestamp":1788964820,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Spyre Therapeutics (SYRE), Autolus Therapeutics (AUT...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-332?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-332?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","HCSG","BK4137","SYRE","LU0029874061.USD","BK4588","XLV","BK4581","LFSC","LU0128526141.USD","BK4139","LABU","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666536420","title":"Analysts Are Bullish on These Healthcare Stocks: IDEAYA Biosciences (IDYA), Medicus Pharma Ltd (MDCX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2666536420","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666536420?lang=en_us&edition=fundamental","pubTime":"2026-09-09 21:40","pubTimestamp":1788961205,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on IDEAYA Biosciences (IDYA) and Medicus Pharma Ltd (MD...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-healthcare-stocks-ideaya-biosciences-idya-medicus-pharma-ltd-mdcx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-healthcare-stocks-ideaya-biosciences-idya-medicus-pharma-ltd-mdcx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0128526141.USD","XBI","XLV","LU0029874061.USD","BK4588","LABU","IDYA","MDCX","BK4137","BK4139","HCSG","BK4585","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666365255","title":"Boan Biotech Confirms Finance Lease Terms After Asset Revaluation","url":"https://stock-news.laohu8.com/highlight/detail?id=2666365255","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666365255?lang=en_us&edition=fundamental","pubTime":"2026-09-09 21:37","pubTimestamp":1788961044,"startTime":"0","endTime":"0","summary":"An update from Shandong Boan Biotechnology Company., Limited. Class H ( ($HK:6955) ) is now available. Shandong Boan Biotechnology Co., Ltd. has co...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/boan-biotech-confirms-finance-lease-terms-after-asset-revaluation?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/boan-biotech-confirms-finance-lease-terms-after-asset-revaluation?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","XBI","BK4581","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666351825","title":"Sector Update: Healthcare Stocks Mixed Premarket Wednesday","url":"https://stock-news.laohu8.com/highlight/detail?id=2666351825","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666351825?lang=en_us&edition=fundamental","pubTime":"2026-09-09 21:16","pubTimestamp":1788959818,"startTime":"0","endTime":"0","summary":"Healthcare stocks were mixed premarket Wednesday, with the State Street Health Care Select Sector SPDR ETF  0.4% higher and the iShares Biotechnology ETF  down 0.3%.InnovAge Holding  shares were up more than 10% after the company reported that it swung to earnings in fiscal Q4 amid stronger-than-expected sales growth.Seaport Therapeutics  stock was nearly 4% higher after the company said its phase 1 driving simulation trial of GlyphAllo met its primary endpoint, with the 375 mg dose showing no next-morning driving impairment versus placebo after multiple-day dosing.Evommune's  phase 2b trial of EVO756 to treat adults with moderate-to-severe atopic dermatitis didn't meet its primary and secondary endpoints in any of the doses studied, the company said. Evommune shares were down more than 8% pre-bell.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4137","BK4139","IBB","BK4007","INNV","LU0029874061.USD","LABU","SPTX","BK4581","XBI","BK4585","BK4588","BK4196","LU0128526141.USD","EVMN","HCSG","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666535154","title":"Metropolis Healthcare Allots 66,312 Shares Under 2020 RSU Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2666535154","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666535154?lang=en_us&edition=fundamental","pubTime":"2026-09-09 21:09","pubTimestamp":1788959383,"startTime":"0","endTime":"0","summary":"An update from Metropolis Healthcare Ltd. ( ($IN:METROPOLIS) ) is now available. Metropolis Healthcare has allotted 66,312 equity shares to employe...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/metropolis-healthcare-allots-66312-shares-under-2020-rsu-plan?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/metropolis-healthcare-allots-66312-shares-under-2020-rsu-plan?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XBI","BK4585","BK4581","HCSG","LABU","XLV","LU0128526141.USD","BK4137","LU0029874061.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666253364","title":"Health Care Select Sector SPDR: Pivot points","url":"https://stock-news.laohu8.com/highlight/detail?id=2666253364","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666253364?lang=en_us&edition=fundamental","pubTime":"2026-09-09 20:39","pubTimestamp":1788957543,"startTime":"0","endTime":"0","summary":"The following are the pivot points for the Health Care Select Sector SPDR (XLV). Pivot High: $167.94, Pivot Low: $166.13. These were calculated usi...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/health-care-select-sector-spdr-pivot-points-thefly-news-138?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/health-care-select-sector-spdr-pivot-points-thefly-news-138?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XBI","LABU","XLV","BK4588","BK4585","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1138959192","title":"Beijing Launches Joint Insurance Body for Biopharma Sector to Strengthen Safeguards for Innovative Medicine Industry","url":"https://stock-news.laohu8.com/highlight/detail?id=1138959192","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1138959192?lang=en_us&edition=fundamental","pubTime":"2026-09-09 20:35","pubTimestamp":1788957348,"startTime":"0","endTime":"0","summary":"According to the Beijing Municipal Science and Technology Commission and the Zhongguancun Administrative Committee, the Beijing Biopharmaceutical Insurance Joint Body has been officially established,...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4581","399441","BK4585","161726","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666538057","title":"Kane Biotech Schedules Webcast to Detail Wound-Care Commercial Strategy","url":"https://stock-news.laohu8.com/highlight/detail?id=2666538057","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666538057?lang=en_us&edition=fundamental","pubTime":"2026-09-09 20:17","pubTimestamp":1788956231,"startTime":"0","endTime":"0","summary":"Kane Biotech ( ($TSE:KNE) ) has shared an announcement. Kane Biotech will host a virtual Commercial Update webcast on September 16, 2026, to brief ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/kane-biotech-schedules-webcast-to-detail-wound-care-commercial-strategy?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/kane-biotech-schedules-webcast-to-detail-wound-care-commercial-strategy?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XBI","BK4585","BK4588","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666090538","title":"Avicanna Expands MyMedi.ca Platform with Integrated Medical Cannabis Program in Canadian Healthcare","url":"https://stock-news.laohu8.com/highlight/detail?id=2666090538","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666090538?lang=en_us&edition=fundamental","pubTime":"2026-09-09 20:16","pubTimestamp":1788956189,"startTime":"0","endTime":"0","summary":"An announcement from Avicanna ( ($TSE:AVCN) ) is now available. Avicanna has launched the MyMedi.ca Integrated Healthcare Program in Canada to embe...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/avicanna-expands-mymedi-ca-platform-with-integrated-medical-cannabis-program-in-canadian-healthcare?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/avicanna-expands-mymedi-ca-platform-with-integrated-medical-cannabis-program-in-canadian-healthcare?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["WEED","BK4588","XBI","HCSG","BK4581","CNBS","MJ","MSOX","LABU","LU0128526141.USD","TOKE","YOLO","XLV","BK4137","BK4585","MSOS","LU0029874061.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666533142","title":"Incannex Healthcare Provides Corporate Update on Clinical Progress, Intellectual Property and Capital Position","url":"https://stock-news.laohu8.com/highlight/detail?id=2666533142","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666533142?lang=en_us&edition=fundamental","pubTime":"2026-09-09 20:00","pubTimestamp":1788955200,"startTime":"0","endTime":"0","summary":"Patient dosing commenced in the DReAMzz Phase 2 dose-optimization study of IHL-42X in obstructive sleep apneaU.S. composition and methods of treatment patent granted covering IHL-42X with baseline exp","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/09/3358577/0/en/incannex-healthcare-provides-corporate-update-on-clinical-progress-intellectual-property-and-capital-position.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0128526141.USD","XBI","XLV","LU0029874061.USD","BK4588","USRD","LABU","PRGS","BK4137","HCSG","LU2065732104.USD","BK4585","BK4097","BK4581"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":17,"pageCount":9,"totalSize":339,"code":"91000000","status":"200"}]}}